FCGR3A and cancer: In addition to HER2 and CD16, several other proteins (e.g., immune checkpoint proteins PD-1 and its partner PD-1L, CD95 a.k.a. Fas receptor and its ligand CD95L a.k.a. Fas ligand) are involved in NK cell cancer cell interactions [36].